橙皮油素改善敌草快中毒小鼠急性肝损伤的机制
该研究将40只SPF级健康雄性C57BL/6小鼠随机分为正常对照组、敌草快中毒模型组、橙皮油素治疗组和橙皮油素对照组,每组10只。敌草快模型通过单次腹腔注射40 mg/kg敌草快水溶液(0.5 mL)建立,造模后4小时治疗组经口灌胃给予0.5 mg/kg橙皮油素水溶液(0.2 mL),每日一次,连续7天。第7天麻醉后采集血液和肝组织,结果显示橙皮油素治疗组较敌草快组血清AST、ALT和肝MDA降低,肝GSH和SOD升高,肝Nrf2和HO-1表达上调、Keap1和活化caspase-9表达下调,差异均有统计学意义。作者结论认为橙皮油素通过激活Keap1/Nrf2信号通路减轻敌草快诱导的小鼠急性肝损伤。
要点
- 小鼠单次腹腔注射40 mg/kg敌草快水溶液(0.5 mL)建立急性肝损伤模型,造模后4小时开始干预。
- 橙皮油素0.5 mg/kg水溶液(0.2 mL)经口灌胃,每日一次,连续7天,为动物实验方案剂量。
- 与敌草快组比较,橙皮油素治疗组血清AST降低(173.45±23.60 vs. 255.33±41.51 U/L)、ALT降低(51.77±21.63 vs. 100.70±32.35 U/L)。
- 与敌草快组比较,橙皮油素治疗组肝MDA降低(12.40±2.76 vs. 19.74±4.10 μmol/g),GSH升高(37.65±14.95 vs. 20.58±8.52 mmol/g),SOD升高(124.10±33.77 vs. 82.81±22.00 kU/g)。
- 电镜下橙皮油素治疗组较敌草快组线粒体肿胀、体积增大、基质溶解、嵴丢失断裂及空泡化显著减轻。
适用人群与场景
- SPF级健康雄性C57BL/6小鼠,共40只,每组10只,用于敌草快诱导急性肝损伤模型实验。
处置流程与药物剂量
- 敌草快中毒模型:单次腹腔注射40 mg/kg敌草快水溶液(0.5 mL);正常对照组和橙皮油素对照组腹腔注射等体积纯水。
- 橙皮油素干预:造模后4小时,治疗组和橙皮油素对照组经口灌胃0.5 mg/kg橙皮油素水溶液(0.2 mL),每日一次,连续7天;正常对照组和敌草快组给予纯水。
- 第7天麻醉后采集血液和肝组织,检测血清ALT、AST及肝GSH、SOD、MDA和蛋白表达。
研究设计与关键结果
- 研究类型为动物实验,40只SPF级健康雄性C57BL/6小鼠随机分为正常对照组、敌草快中毒模型组、橙皮油素治疗组和橙皮油素对照组,每组10只。
- 与敌草快组比较,橙皮油素治疗组血清AST降低(173.45±23.60 vs. 255.33±41.51 U/L)、ALT降低(51.77±21.63 vs. 100.70±32.35 U/L),差异有统计学意义(均P<0.05)。
- 与敌草快组比较,橙皮油素治疗组肝MDA降低(12.40±2.76 vs. 19.74±4.10 μmol/g),GSH升高(37.65±14.95 vs. 20.58±8.52 mmol/g),SOD升高(124.10±33.77 vs. 82.81±22.00 kU/g),差异有统计学意义(均P<0.05)。
- Western blotting显示,与敌草快组比较,橙皮油素治疗组肝Nrf2表达上调(Nrf2/β-actin:0.87±0.37 vs. 0.53±0.22)、HO-1表达上调(HO-1/β-actin:1.06±0.22 vs. 0.49±0.08),Keap1表达下调(Keap1/β-actin:0.82±0.12 vs. 1.52±0.76)、活化caspase-9表达下调(活化caspase-9/β-actin:1.16±0.28 vs. 1.71±0.30),差异有统计学意义(均P<0.05)。
- 透射电镜显示,敌草快组线粒体明显肿胀、体积增大、基质溶解、嵴丢失断裂及广泛空泡化,橙皮油素治疗组上述改变较敌草快组显著减轻。
证据类型、等级与局限
- 证据类型:动物实验(小鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为小鼠实验,作者结论认为橙皮油素通过激活Keap1/Nrf2信号通路减轻敌草快诱导的急性肝损伤,尚未提供临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether auraptene (AUR) exerts a protective effect on acute diquat (DQ)-induced liver injury in mice and explore its underlying mechanisms.
METHODS: Forty SPF-grade healthy male C57BL/6 mice were randomly divided into normal control group (Control group), DQ poisoning model group (DQ group), AUR treatment group (DQ+AUR group), and AUR control group (AUR group), with 10 mice in each group. The DQ poisoning model was established via a single intraperitoneal injection of 40 mg/kg DQ aqueous solution (0.5 mL); Control group and AUR group received an equal volume of pure water intraperitoneally. Four hours post-modeling, DQ+AUR group and AUR group were administered 0.5 mg/kg AUR aqueous solution (0.2 mL) by gavage once daily for 7 consecutive days, while Control group and DQ group received pure water. Blood and liver tissues were collected after anesthesia on day 7. Liver ultrastructure was observed by transmission electron microscopy. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured via enzyme-linked immunosorbent assay (ELISA). Hepatic glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde (MDA) levels were detected using WST-1, thiobarbituric acid (TBA), and enzymatic reaction methods, respectively. Protein expression of nuclear factor-erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), Kelch-like ECH-associated protein 1 (Keap1), and activated caspase-9 in liver tissues was analyzed by Western blotting.
RESULTS: Transmission electron microscopy revealed that mitochondria in the Control group exhibited mild swelling, uneven distribution of matrix, and a small number of cristae fractures. In the AUR group, mitochondria showed mild swelling, with no obvious disruption of cristae structure. In the DQ group, mitochondria demonstrated marked swelling and increased volume, matrix dissolution, loss and fragmentation of cristae, and extensive vacuolization. In contrast, the DQ+AUR group showed significantly reduced mitochondrial swelling, volume increase, matrix dissolution, cristae loss and fragmentation, and vacuolization compared to the DQ group. Compared with the DQ group, the DQ+AUR group exhibited significantly lower serum AST levels (U/L: 173.45±23.60 vs. 255.33±41.51), ALT levels (U/L: 51.77±21.63 vs. 100.70±32.35), and hepatic MDA levels (μmol/g: 12.40±2.76 vs. 19.74±4.10), along with higher hepatic GSH levels (mmol/g: 37.65±14.95 vs. 20.58±8.52) and SOD levels (kU/g: 124.10±33.77 vs. 82.81±22.00), the differences were statistically significant (all P < 0.05). Western blotting showed upregulated Nrf2 expression (Nrf2/β-actin: 0.87±0.37 vs. 0.53±0.22) and HO-1 expression (HO-1/β-actin: 1.06±0.22 vs. 0.49±0.08), and downregulated Keap1 expression (Keap1/β-actin: 0.82±0.12 vs. 1.52±0.76) and activated caspase-9 expression (activated caspase-9/β-actin: 1.16±0.28 vs. 1.71±0.30) in the DQ+AUR group compared to the DQ group (all P < 0.05).
CONCLUSION: AUR attenuates DQ-induced acute liver injury in mice by activating the Keap1/Nrf2 signaling pathway.
参考来源
- Ou R, Huang S, Ma L, et al. [Mechanism of auraptene in improving acute liver injury induced by diquat poisoning in mice]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40820536. doi:10.3760/cma.j.cn121430-20250113-00043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。